English
This article is from Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences , volume 19 . Abstract Background:: Hypercoagulability has been reported in primary brain tumors which can lead to thrombotic complications. Hydroxyethyl starch (hetastarch) is a synthetic colloid solution with adverse effects on blood coagulation. The aim of this study was to evaluate the protective effect of hetastarch in reducing thromboembolic events in these patients. Materials and Methods:: In a double-blinded clinical trial, 60 brain tumor surgery patients were randomly divided into two groups and given 10 mL/kg hetastarch or normal saline during surgery. Blood coagulation was compared before and after infusion of these fluids within and between groups by thromboelastography (TEG). Results:: There were no significant differences in bleeding (P = 0.126), duration of surgery (P = 0.504), and fluid intake (0.09L) between the two groups. Percentage of changes in R (R: Time to initiate fibrin formation), K (K: Measure of the speed taken to reach a specific level of clot strength), and Ly30 (Ly30: Percent of fibrin distraction after 30 minutes of clot forma
Sign in with your free account to read, download EPUBs or listen.
Ebook · Comparative evaluation of the effects of hydroxyethyl starch on coagulation state of patients during brain tumor surgeries in comparison to crystalloids by thromboelastography. · Golparvar, Mohammad, Saghaei, Mahmood, Hamidi, Hossein, Sajedi, Parvin, Kashefi, Parviz, Aghadavoudi, Omid, Abbasi, Saeed · Internet Archive